CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 73  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0544
LYS 10.0363
GLU 20.0372
LEU 30.0475
ARG 40.0544
CYS 50.0362
GLN 60.0504
CYS 70.0086
ILE 80.0343
LYS 90.0410
THR 100.0144
TYR 110.0196
SER 120.0340
LYS 130.0485
PRO 140.0229
PHE 150.0105
HIS 160.0143
PRO 170.0126
LYS 180.0174
PHE 190.0100
ILE 200.0119
LYS 210.0069
GLU 220.0098
LEU 230.0125
ARG 240.0298
VAL 250.0295
ILE 260.0359
GLU 270.0149
SER 280.0236
GLY 290.0194
PRO 300.0379
HIS 310.0212
CYS 320.0152
ALA 330.0166
ASN 340.0385
THR 350.0122
GLU 360.0205
ILE 370.0113
ILE 380.0067
VAL 390.0045
LYS 400.0093
LEU 410.0103
SER 420.0111
ASP 430.0118
GLY 440.0065
ARG 450.0047
GLU 460.0068
LEU 470.0027
CYS 480.0032
LEU 490.0115
ASP 500.0275
PRO 510.0245
LYS 520.0197
GLU 530.0196
ASN 540.0206
TRP 550.0136
VAL 560.0191
GLN 570.0188
ARG 580.0113
VAL 590.0033
VAL 600.0088
GLU 610.0098
LYS 620.0139
PHE 630.0168
LEU 640.0247
LYS 650.0479
ARG 660.0319
ALA 670.0493
GLU 680.0213
ASN 690.0222

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.